Company Overview
Forian Inc. operates within the healthcare sector, specifically focusing on the health information services industry, where it delivers specialized data management capabilities and analytics solutions designed to optimize operational, clinical, and financial performance across life science, healthcare, and financial services sectors. The company develops commercial and real-world evidence solutions that enable customers to measure and enhance their performance metrics through advanced information technology. In terms of scale, Forian Inc. maintains a market capitalization of $64.01M and employs 47 individuals to support its suite of data management and analytics offerings. While the market cap of $64.01M places the entity in a smaller-cap category relative to large pharmaceutical or technology conglomerates, the annual revenue of $28.11M combined with a significant revenue growth rate suggests the company is expanding its operational footprint despite its modest employee count. The revenue figure of $28.11M indicates that the business generates substantial income relative to its workforce size, reflecting high productivity or a niche market position within the health information services landscape.
Financial Health
The company reported revenue of $28.11M over the trailing twelve months, yet posted a net income of $-852,578 and an EBITDA of $-3,553,923, revealing a cost structure where operational expenses significantly outpace gross profits before interest and taxes. This gap between the positive revenue of $28.11M and negative net income indicates that the company is currently investing heavily in growth or sustaining high burn rates that have not yet been offset by profitability. Despite the negative earnings, Forian Inc. generated free cash flow of $1.82M, which provides a critical buffer for financial flexibility by allowing the company to fund operations or strategic initiatives without relying solely on external financing. The gross margin stands at 55.4%, suggesting that the company retains a healthy portion of revenue after direct costs, while the operating margin of -6.1% and profit margin of -3.0% highlight that overhead and other expenses are currently eroding profitability. On the balance sheet, the company holds cash of $28.23M against a debt level of $18,097, resulting in a debt-to-equity ratio of 0.06, which indicates a highly conservative and unleveraged financial position with minimal fixed obligations. The current ratio is 3.87, a figure that demonstrates strong short-term liquidity as the company possesses nearly four times the current assets required to meet its short-term liabilities. Furthermore, the return on equity is -2.9% and the return on assets is -4.7%, metrics that reveal management is currently generating negative returns on the capital invested, a common characteristic for high-growth companies in the early stages of scaling.
Valuation Assessment
Valuation multiples for Forian Inc. include a trailing P/E ratio of N/A and a forward P/E of 22.89, a disparity that implies the market prices the stock based on anticipated future earnings rather than current profitability, often seen in companies expecting a turnaround or significant expansion. The price-to-book ratio is 2.05, indicating that the stock trades at a premium of roughly double its book value, which may reflect investor confidence in the company's intangible assets or future revenue potential despite current losses. Alternative valuation metrics such as the price-to-sales ratio of 2.28 and an EV/EBITDA of -10.07 suggest that investors are valuing the company based on revenue generation and enterprise value rather than current earnings power, as the negative EV/EBITDA reflects the pre-profitability status. The stock has traded within a 52-week range bounded by a high of $2.71 and a low of $1.64, and without a specific current price provided in the facts, the trading position relative to this range can only be characterized by these historical bounds. The beta value is 1.03, which signifies that the stock's price volatility is slightly higher than the broader market, meaning it tends to move in tandem with the market but with a marginally increased sensitivity to market swings.
Growth & Income
Forian Inc. exhibits a revenue growth rate of 65.6% year-over-year, while the earnings growth rate is N/A due to the company's negative net income, implying that top-line expansion is occurring faster than bottom-line profitability can currently catch up. As a non-dividend payer, the company does not distribute a dividend yield or maintain a payout ratio, which means the company reinvests all available earnings back into the business to fuel growth initiatives rather than returning capital to shareholders. This reinvestment strategy is typical for companies in the health information services sector that prioritize scaling their data management capabilities and real-world evidence development over immediate income distribution. The overall growth and income profile is characterized by robust revenue acceleration and a complete absence of dividend income, positioning the asset as a pure-play growth opportunity rather than an income-generating holding.